EATG » News

Statements from the European HIV-Hepatitis Testing Week Working Group

The European Testing Week Working Group has released two statements supporting safer and voluntary testing for key and most affected populations for HIV and hepatitis. The first is a statement…

Webinar: EUPATI Online Toolbox

Webinar: EUPATI Online Toolbox – resources about medicines research for patient advocates Tuesday 21 November 17.00 – 18.00 CET Please register here: https://attendee.gotowebinar.com/register/1320863496295663618 After registering, you will receive a confirmation…

Open letter to the Romanian MoH to focus on TB

The Romanian Health Observatory, supported by the Romanian Angel Appeal Foundation (RAA) under the Global Fund programme, has published “The Crisis of Anti-TB Medicines in Romania”, a comprehensive and evidence-based…

ACHIEVE Coalition sends open letter to Romanian MoH

The ACHIEVE Coalition sent this open letter to the Minister of Health of Romania today. The letter, co-signed by EATG as a member of ACHIEVE, calls the Romanian government to…

CoPE Call for Applications

We are pleased to announce a special CoPE call for hepatitis, addressing the need for access to hepatitis prevention, testing, treatment and care services by co-infected key populations. Please find below…

World Hepatitis Summit – Declaration of the Hepatitis Community

The World Hepatitis Summit passed and published the Declaration of the Hepatitis Community "NO ELIMINATION WITHOUT DECRIMINALIZATION!" today. The Declaration calls for the decriminalization of people who use drugs, and…

Major European men who have sex with men internet survey, EMIS 2017, launched

A major online survey for gay, bisexual and other men who have sex with men has just been launched across Europe in 33 languages. The European Men-who-have-sex-with-men Internet Survey (EMIS…

Hepatitis webinars: The entire collection from the HAND project

In the framework of the HAND - Hepatitis Access Needs Project, EATG has produced a series of webinars about hepatitis treatment and prevention in English and Russian. To watch the…

Joint NGO statement on health sustainability in trade and investment agreements

Last week EATG contributed to this joint statement at a Civil Society Dialogue meeting on EU trade policy and Sustainable Development with European Commissioner Malmström (Trade). The reason the subject matters…

Testing Week Statement on Most Affected Populations – Read and Share

Anticipating the upcoming European HIV-Hepatitis Testing Week, an alliance of NGOs has issued the following statement in support of reaching out to and involving most affected populations in HIV and…

EATG signs on call to action for reconsidering primary HIV prevention

Reconsidering primary prevention: Call to action for the global HIV response The world needs a new phase in the evolution of the HIV response – one that reinvigorates prevention by…

ECHOES survey now LIVE: Community Health Workers are invited to provide input!

The ECHOES survey is now LIVE - Community Health Workers who provide sexual health and support services for MSM in the EU and neighbouring countries are invited to participate NOW…

EATG signs on joint statement from civil society organisations on the situation faced by the LGBTI community in Azerbaijan

Mass detention of Azeri LGBTI people– the LGBTI community urgently needs your support Alarming stories of physical violence, verbal abuse, forced medical examinations and detentions of LGBTI people have been…

Hepatitis prevention webinar – Register now!

EATG and the HAND - Hepatitis Access Needs Project would like to invite you to the upcoming webinar on Prevention of Hepatitis B and C that will take place on Monday, 16 October 2017,…

Register now! Webinar on hepatitis B treatment

EATG invites you to a community oriented webinar on Hepatitis B Treatment that will take place on Monday, 18 September 2017, 15:00 – 16:00 CET. The webinar will be held by…

EATG signs on submission to the European Commission on SPC review

Over 30 civil society organisations urge EU to abolish supplementary protection certificates mechanism In an open letter and open submission, thirty-three civil society organisations have called on the European Commission…

Register now! Webinar on regulatory approval of medicines

EATG invites you to a community oriented webinar on the Regulatory Approval Processes of Medicines that will take place on Wednesday, 13 September 2017, 15:00 – 16:00 CET. The webinar will be held…

Register now! Webinar on hepatitis C treatment

EATG invites you to a community oriented webinar on Hepatitis C Treatment that will take place on Tuesday, 12 September 2017, 15:00 – 16:00 CET. The webinar will be held by Prof.…

STEPS IV Cure Workshop in Milan on 24/10/2017

If you are planning to attend the EACS meeting in Milan, Italy (October 25-27), you are invited to apply to the fourth community meeting focused on HIV cure, therapeutic vaccines…

Conference invitation – From HIV testing and linkage to care to the integration of HIV, Hepatitis, TB & STIs

We are pleased to inform you about the European conference “from HIV testing and linkage to care to the integration of HIV, Hepatitis, TB & STIs” that will take place…

Statements from the European HIV-Hepatitis Testing Week Working Group

The European Testing Week Working Group has released two statements supporting safer and voluntary testing for key and most affected populations for HIV and hepatitis. The first is a statement…

Webinar: EUPATI Online Toolbox

Webinar: EUPATI Online Toolbox – resources about medicines research for patient advocates Tuesday 21 November 17.00 – 18.00 CET Please register here: https://attendee.gotowebinar.com/register/1320863496295663618 After registering, you will receive a confirmation…

First European community PrEP center opens in Barcelona

The first European community center dedicated to the HIV/AIDS prevention pill opens in Barcelona BCN PrEP·Point follows up with individuals who take the medication “on their own accord” and aims…

Second-generation vaginal films address issues with current HIV prevention methods

Developing a new vaccination strategy against AIDS

The type of vaccine administered and the activation of the body's own immune cells influence the vaccine protection According to the WHO, there are currently more than 36 million people…

No change in cognitive function or brain structure in people taking effective HIV treatment for 2 years

People with HIV taking antiretroviral treatment who had undetectable viral load did not suffer any loss of cognitive function or brain volume during a two-year period when compared with their…

Long-term data do not support raltegravir as second-line HIV therapy

A second-line HIV regimen containing the integrase inhibitor raltegravir failed to meet its primary endpoint of noninferiority against standard second-line treatment with nucleoside reverse-transcriptase inhibitors, or NRTIs, according to 144-week…

GeoVax HIV clinical trials update

Participant enrollment completed for HVTN 114 trial 15 November 2017: GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced that the HIV Vaccine Trials Network (HVTN)…

Theratechnologies announces FDA decision to extend the ibalizumab review period

Theratechnologies Inc. announced that it was notified by its partner, TaiMed Biologics, Inc., that the U.S. Food and Drug Administration will extend its review of the Biologics License Application for…

Global Fund appoints Peter Sands as Executive Director

Aidspan publishes two new issues of ‘Global Fund Observer’

Reduced risk of hepatic steatosis in HIV/HCV coinfection with cannabis use

Daily cannabis use was shown to be associated with a reduced risk for liver steatosis among individuals co-infected with HIV and hepatitis C, according to the results of a recent…

DAAs produce cure rates in HCV/HIV co-infection similar to monoinfection

Using direct-acting antiviral therapies demonstrated similarly high rates of sustained virologic response for hepatitis C virus infection in patients with and without HIV infection as compared with rates for HCV…

FDA approves hepatitis C drugs label updates

FDA recently approved changes to the labels of: Sovaldi (sofosbuvir), Harvoni (ledipasvir and sofosbuvir), Epclusa (sofosbuvir and velpatasvir) and Vosevi (sofosbuvir, velpatasvir, and voxilaprevir). The approved changes are detailed here.…

Open letter to the Romanian MoH to focus on TB

The Romanian Health Observatory, supported by the Romanian Angel Appeal Foundation (RAA) under the Global Fund programme, has published “The Crisis of Anti-TB Medicines in Romania”, a comprehensive and evidence-based…

Join MSF and Stop TB Partnership in asking countries to #StepUpforTB

Join Médecins Sans Frontières (MSF) and the Stop TB Partnership in a call to action to #StepUpforTB by signing and sharing a petition by 14 November 2017. The petition will…

Vital microbicides may soon be out of reach

Whether, when, and how microbicide development proceeds depends on the U.S government, and the federal Division of AIDS has suggested this development may no longer be a priority. It's wrong.…

Russia’s methadone ban is fueling an HIV epidemic in Crimea

Georgy’s drug addiction started when he was just 15. It began with the painkillers doctors gave him after he fractured his hip. But tension at home made it difficult to…

A modest increase in U.S. investment to fight HIV/AIDS in sub-Saharan Africa could prevent 22 million new HIV infections by 2032

Analysis examines historical and potential impact of U.S. global health funding in region bearing heavy HIV/AIDS burden NEW YORK, Nov. 10, 2017 – A new analysis shows that nearly 5…

World Antibiotic Awareness Week 13-19 November to draw attention to global AMR threat

World Antibiotic Awareness Week will take place next week from 13-19 November, shining a spotlight on the growing crisis of antimicrobial resistance (AMR). The first descriptions of infectious diseases becoming…